{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:12:03Z","timestamp":1790431923285,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.regpep.2006.04.021","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T11:22:32Z","timestamp":1157196152000},"page":"67-74","source":"Crossref","is-referenced-by-count":28,"title":["Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions"],"prefix":"10.1016","volume":"137","author":[{"given":"Alejo","family":"Chorny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gonzalez-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niveves","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Robledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2006.04.021_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/pr.56.2.7","article-title":"The significance of vasoactive intestinal peptide in immunomodulation","volume":"56","author":"Delgado","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.regpep.2006.04.021_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0031-6997(24)01360-7","article-title":"International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide","volume":"50","author":"Harmar","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.regpep.2006.04.021_bib3","first-page":"4","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP\/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland","volume":"17","author":"Rawlings","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.regpep.2006.04.021_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0167-4889(97)00104-3","article-title":"Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages","volume":"1359","author":"Pozo","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.regpep.2006.04.021_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1749-6632.2000.tb06964.x","article-title":"Differential activation of phospholipase D by VPAC and PAC1 receptors","volume":"921","author":"McCulloch","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2006.04.021_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/365170a0","article-title":"Differential signal transduction by five splice variants of the PACAP receptor","volume":"365","author":"Spengler","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2006.04.021_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0196-9781(92)90055-8","article-title":"Guanine nucleotide regulation of VIP binding to rat peritoneal macrophage membranes","volume":"13","author":"Segura","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2006.04.021_bib8","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.127.6.2551","article-title":"Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase","volume":"127","author":"O'Dorisio","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.17.1.593","article-title":"Mechanisms of phagocytosis in macrophages","volume":"17","author":"Aderem","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1146\/annurev.pa.35.040195.003255","article-title":"Macrophages and inflammatory mediators in tissue injury","volume":"35","author":"Laskin","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.regpep.2006.04.021_bib12","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/jlb.63.5.591","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages","volume":"63","author":"Martinez","year":"1998","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.regpep.2006.04.021_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0165-5728(98)00140-4","article-title":"Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages","volume":"89","author":"Xin","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0165-2478(97)00129-6","article-title":"The vasoactive intestinal peptide analogue RO25-1553 inhibits the production of TNF and IL-12 by LPS-activated monocytes","volume":"60","author":"Dewit","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.regpep.2006.04.021_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-5728(96)00118-X","article-title":"Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha production by whole blood cells from healthy young and old subjects","volume":"71","author":"Hernanz","year":"1996","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-001-0291-5","article-title":"Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases","volume":"80","author":"Delgado","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.regpep.2006.04.021_bib17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1749-6632.1999.tb07909.x","article-title":"VIP and PACAP38 modulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines","volume":"897","author":"Delgado","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2006.04.021_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-5728(99)00023-5","article-title":"VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells","volume":"96","author":"Delgado","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib19","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4049\/jimmunol.162.3.1707","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib20","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.162.8.4685","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib21","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.162.4.2358","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib22","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1002\/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L","article-title":"Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock","volume":"30","author":"Delgado","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1073\/pnas.012367999","article-title":"Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor","volume":"99","author":"Martinez","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2006.04.021_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0031-6997(24)01449-2","article-title":"Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions","volume":"52","author":"Vaudry","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.regpep.2006.04.021_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib26","doi-asserted-by":"crossref","first-page":"31427","DOI":"10.1074\/jbc.273.47.31427","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-\u03baB and cAMP response element-binding protein\/c-Jun","volume":"273","author":"Delgado","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2006.04.021_bib27","doi-asserted-by":"crossref","first-page":"31930","DOI":"10.1074\/jbc.274.45.31930","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation","volume":"274","author":"Delgado","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2006.04.021_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1074\/jbc.M006923200","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1","volume":"276","author":"Delgado","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2006.04.021_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1189\/jlb.0702372","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the production of inflammatory mediators by activated microglia","volume":"73","author":"Delgado","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.regpep.2006.04.021_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/glia.10098","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit chemokine production in activated microglia","volume":"39","author":"Delgado","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.regpep.2006.04.021_bib31","first-page":"103","article-title":"The multifunctional role of the co-activator CBP in transcriptional regulation","volume":"52","author":"Goldman","year":"1997","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.regpep.2006.04.021_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/370223a0","article-title":"Nuclear protein CBP is a coactivator for the transcription factor CREB","volume":"370","author":"Kwok","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2006.04.021_bib33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/365855a0","article-title":"Phosphorylated CREB binds specifically to the nuclear protein CBP","volume":"365","author":"Chrivia","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2006.04.021_bib34","doi-asserted-by":"crossref","first-page":"17795","DOI":"10.1074\/jbc.272.28.17795","article-title":"Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors","volume":"272","author":"Yao","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2006.04.021_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-5728(00)00359-3","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1\/MEK4\/JNK signaling pathway in LPS-stimulated macrophages","volume":"110","author":"Delgado","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0006-291X(02)00283-8","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1\/MEK4\/JNK signaling pathway in endotoxin-activated microglia","volume":"293","author":"Delgado","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.regpep.2006.04.021_bib37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","article-title":"Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation","volume":"81","author":"Kyriakis","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.regpep.2006.04.021_bib38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation","volume":"9","author":"Karin","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.regpep.2006.04.021_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0092-8674(89)90754-X","article-title":"Jun-B differs in its biological properties from, and is a negative regulator of c-Jun","volume":"59","author":"Chiu","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.regpep.2006.04.021_bib40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0092-8674(89)90755-1","article-title":"Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun","volume":"59","author":"Schutte","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.regpep.2006.04.021_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","article-title":"The IFN gamma receptor: a paradigm for cytokine receptor signaling","volume":"15","author":"Bach","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib42","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.4049\/jimmunol.165.6.3051","article-title":"Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide","volume":"165","author":"Delgado","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib43","doi-asserted-by":"crossref","first-page":"27620","DOI":"10.1074\/jbc.M303199200","article-title":"Inhibition of interferon (IFN) gamma-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide: inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression","volume":"278","author":"Delgado","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2006.04.021_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.183.1.147","article-title":"The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells","volume":"183","author":"Ma","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.regpep.2006.04.021_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2003.tb03145.x","article-title":"PACAP in immunity and inflammation","volume":"992","author":"Delgado","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2006.04.021_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2005.038232","article-title":"Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome","volume":"65","author":"Lodde","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.regpep.2006.04.021_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/87887","article-title":"Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease","volume":"7","author":"Delgado","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.regpep.2006.04.021_bib48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/gast.2003.50141","article-title":"Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease","volume":"124","author":"Abad","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.regpep.2006.04.021_bib49","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archopht.122.8.1179","article-title":"Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide","volume":"122","author":"Keino","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.regpep.2006.04.021_bib50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.162.2.1200","article-title":"VIP and PACAP protect mice from lethal endotoxemia through the inhibition of TNFa and IL-6","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib51","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2353\/ajpath.2006.051081","article-title":"Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: downregulation of inflammatory and autoimmune responses","volume":"168","author":"Gonzalez-Rey","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.regpep.2006.04.021_bib52","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1096\/fj.02-0799fje","article-title":"Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglia activation","volume":"17","author":"Delgado","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.regpep.2006.04.021_bib53","doi-asserted-by":"crossref","first-page":"R1034","DOI":"10.1186\/ar1779","article-title":"Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis","volume":"7","author":"Juarranz","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.regpep.2006.04.021_bib54","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.4049\/jimmunol.175.11.7311","article-title":"The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells","volume":"175","author":"Delgado","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.regpep.2006.04.021_bib55","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1073\/pnas.0504484102","article-title":"Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders","volume":"102","author":"Chorny","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2006.04.021_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011506001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011506001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T19:01:09Z","timestamp":1736535669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011506001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":56,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0167011506001212"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2006.04.021","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}